IL-17A

Shanghai, China, July 1, 2026 Junshi Biosciences has entered into a landmark licensing collaboration with Fosun Wanbang Pharma Group,...

Basel, Switzerland, July 2, 2026 Novartis has achieved a major milestone in the treatment of spinal muscular atrophy (SMA)...

ZUG, Switzerland, June 21, 2026 MoonLake Immunotherapeutics has announced compelling Week 52 results from its Phase 3 VELA clinical...

OAKVILLE, Ontario, June 9, 2026 UCB Canada announced that BIMZELX® (bimekizumab injection) received a positive reimbursement recommendation with conditions...

Indianapolis, USA | March 28, 2026 Phase 3b Study Demonstrates Superior Clinical Outcomes Eli Lilly and Company has announced...